Literature DB >> 12711449

In vitro skin permeation and retention of 5-aminolevulinic acid ester derivatives for photodynamic therapy.

Fernanda Scarmato De Rosa1, Antônio Cláudio Tedesco, Renata Fonseca Vianna Lopez, Maria Bernadete Riemma Pierre, Norbert Lange, Juliana Maldonado Marchetti, Jeane Cristina Gomes Rotta, Maria Vitória Lopes Badra Bentley.   

Abstract

In photodynamic therapy (PDT), 5-aminiolevulinic acid (5-ALA) applied topically is converted, via the heme cycle, into protoporphyrin IX (PpIX), a photosensitizing agent, which upon excitation with light can induce tumor destruction. Due to its hydrophilic and zwitterionic characteristics, 5-ALA has limited penetration into the skin. More lipophilic 5-ALA ester derivatives are expected to cross stratum corneum more easily than 5-ALA. According to the determination of the partition coefficients of 5-ALA methyl, n-butyl, n-hexyl and n-octyl esters, these compounds showed an increased affinity to the SC, with 5-ALA hexyl ester and 5-ALA-octyl ester having the highest partition coefficients. Our in vitro skin permeation studies demonstrated an increased permeated amount for hexyl-ALA after 6 h of incubation, compared to other esters and 5-ALA. After 6 h, more 5-ALA-hexyl ester and -octyl ester were retained at viable epidermis and dermis than 5-ALA. According to these results, and considering that the conversion of 5-ALA into PpIX occurs preferentially in epidermis, it can be supposed that topical use of ester derivatives with longer chains (C(6) or C(8)) is an interesting proposal to optimize topical 5-ALA-PDT

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12711449     DOI: 10.1016/s0168-3659(03)00125-1

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  7 in total

1.  Oleic acid as optimizer of the skin delivery of 5-aminolevulinic acid in photodynamic therapy.

Authors:  Maria Bernadete Riemma Pierre; Eduardo Ricci; Antonio Cláudio Tedesco; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2006-01-01       Impact factor: 4.200

2.  A novel transdermal delivery system for the anti-inflammatory lumiracoxib: influence of oleic acid on in vitro percutaneous absorption and in vivo potential cutaneous irritation.

Authors:  Tailane Sant'Anna Moreira; Valéria Pereira de Sousa; Maria Bernadete Riemma Pierre
Journal:  AAPS PharmSciTech       Date:  2010-04-07       Impact factor: 3.246

3.  In vitro metabolism of 5-ALA esters derivatives in hairless mice skin homogenate and in vivo PpIX accumulation studies.

Authors:  Fernanda Scarmato De Rosa; Renata Fonseca Vianna Lopez; José Antônio Thomazine; Antônio Cláudio Tedesco; Norbert Lange; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2004-12       Impact factor: 4.200

4.  Development of lapachol topical formulation: anti-inflammatory study of a selected formulation.

Authors:  Ana Amélia M Lira; Elizângela A Sester; André Luis M Carvalho; Ruth R Strattmann; Miracy M Albuquerque; Almir G Wanderley; Davi P Santana
Journal:  AAPS PharmSciTech       Date:  2008-01-25       Impact factor: 3.246

5.  Gel Formulation of Nabumetone and a Newly Synthesized Analog: Microemulsion as a Photoprotective Topical Delivery System.

Authors:  Fedora Grande; Gaetano Ragno; Rita Muzzalupo; Maria Antonietta Occhiuzzi; Elisabetta Mazzotta; Michele De Luca; Antonio Garofalo; Giuseppina Ioele
Journal:  Pharmaceutics       Date:  2020-05-05       Impact factor: 6.321

6.  Derivatives of 5-aminolevulinic Acid for photodynamic therapy.

Authors:  Ryan F Donnelly; Paul A McCarron; A David Woolfson
Journal:  Perspect Medicin Chem       Date:  2007-12-11

7.  Experimental investigation of a combinational iron chelating protoporphyrin IX prodrug for fluorescence detection and photodynamic therapy.

Authors:  Anette Magnussen; Charlotte Reburn; Alexis Perry; Mark Wood; Alison Curnow
Journal:  Lasers Med Sci       Date:  2021-07-04       Impact factor: 3.161

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.